Trial Profile

Therapeutic Impact of THN102 on Attention, Wakefulness and Cognitive Performance During Total Sleep Deprivation in Healthy Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 20 Aug 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Flecainide/modafinil (Primary) ; Modafinil
Indications Hypersomnia; Narcolepsy
Focus First in man; Proof of concept; Therapeutic Use
Sponsors Theranexus

Most Recent Events

16 Aug 2019 Results published in the British Journal of Clinical Pharmacology
04 Oct 2016 According to a Theranexus media release, results from this study were recently presented in partnership with the French Armed Forces Biomedical Research Institute (IRBA), during the latest congress held by the European Sleep Research Society (ESRS 2016).
17 May 2016 Results published in a Theranexus media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com